Capacitive Diathermy in the Lumbopelvic Pain (T-Care)

October 6, 2016 updated by: European University of Madrid

Mechanosensitivity, Morphological, Functional and Contractility Changes by the Capacitive Diathermy in Subjects With Lumbopelvic Pain: a Pilot Study, Single Blind, Randomized Controlled Clinical Trial

Objective: To determine the effectiveness of the capacitive diathermy in the mechanosensitivity, morphological, functional and contractility changes in patients with lumbopelvic pain.

Design: A pilot study, single blind, randomized controlled clinical trial, approved previously by The Princess University Hospital Ethics Committee (Feb 11, 2016) and the European University clinical intervention review board (CIPI/054/15).

Setting: Faculty of Health Sciences, Exercise and Sport. European University of Madrid.

Patients and intervention: A sample of 20 patients with bilateral lumbopelvic pain, between 18 and 60 years old, will be recruited and randomized into 2 intervention groups. The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe®on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe®off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.

Outcome measurements: Control variables such as the age, sex, height, weight, body mass index, Borg scale physical activity and distress respiratory test will be measured at the beginning of the treatment. Dependent variables such as the pain intensity, the pressure pain threshold, the contractility, the stiffness, the adverse effects, the Oswestry and Schöber test, as well as the ultrasound imaging cross sectional area and thickness of the skin, subcutaneous tissue, connective tissue, L4 multifidus and the abdominal Wall (rectus anterior, externus oblique, internal oblique and transversus abdominis) will be assessed before and after each intervention by a blinded examiner.

Analysis data: The statistical analysis will be performed with a 95% confidence interval and the Statistic Package Social Sciences (SPSS) 22.0.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Villaviciosa de Odón, Madrid, Spain, 28670
        • Recruiting
        • European University of Madrid
        • Contact:
        • Principal Investigator:
          • César Calvo Lobo, PhD, MSc, PT
        • Principal Investigator:
          • David Rodríguez Sanz, PhD, MSc, PT
        • Sub-Investigator:
          • Beatriz Martínez Pascual, PhD, MSc, PT
        • Sub-Investigator:
          • Silvia Fernández Martínez, PhD, MSc, PT
        • Sub-Investigator:
          • Mónica de la Cueva Reguera, PhD, MSc, PT
        • Sub-Investigator:
          • Ignacio Diez Vega, PhD, MSc, PT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • bilateral lumbopelvic pain for 6 weeks

Exclusion Criteria:

  • neuromuscular conditions
  • negative straight leg raise test
  • respiratory or congenital conditions
  • surgeries
  • neurologic signs
  • lower extremities conditions
  • skin alterations
  • cognitive disorders
  • body mass index higher than 31 kg/cm2
  • skin alterations
  • pregnancy
  • intensive physical activity
  • Nijmegen test higher than 24

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IMT+ T-CaRe®on; n = 10
The instrumental manual therapy with the switched on capacitive diathermy electrode
The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe® on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe® off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.
Bilateral longitudinal massage in the lumbar region (110 mm; 5 minutes in each side)
Sham Comparator: IMT+ T-CaRe® off; n = 10
The instrumental manual therapy with the switched off capacitive diathermy electrode
The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe® on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe® off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.
Bilateral longitudinal massage in the lumbar region (110 mm; 5 minutes in each side)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity from 0 to 10
Time Frame: 4 weeks
Visual analogue scale
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure pain threshold in kg/cm^2
Time Frame: 4 weeks
Analogue pressure algometer (Mechanical algometer)
4 weeks
Contractility time in seconds
Time Frame: 4 weeks
Electrical stimulator
4 weeks
Stiffness by the mean strain ratio (proportion) by Sonoelastography
Time Frame: 4 weeks
The mean strain ratio by Sonoelastography
4 weeks
Adverse effects (yes or no)
Time Frame: 4 weeks
4 weeks
Oswestry test from 0 to 100
Time Frame: 4 weeks
4 weeks
Schöber test in centimeters
Time Frame: 4 weeks
4 weeks
Cross sectional area (cm^2) in centimeters
Time Frame: 4 weeks
Ultrasound imaging (cm^2) in the L4 multifidus of the low back region and the rectus anterior of the abdominal wall. Diagnostic ultrasound system.
4 weeks
Thickness in centimeters
Time Frame: 4 weeks
Ultrasound imaging (cm) in the skin, subcutaneous tissue, connective tissue, L4 multifidus and the abdominal Wall (rectus anterior, external oblique, internus oblique and transversus abdominis). Diagnostic ultrasound system
4 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Age in years.
Time Frame: 1 day
1 day
Sex (men / women)
Time Frame: 1 day
1 day
height in meters
Time Frame: 1 day
1 day
weight in kilograms
Time Frame: 1 day
1 day
body mass index in kg/m^2
Time Frame: 1 day
1 day
Borg physical scale from 0 to 10
Time Frame: 1 day
1 day
Nijmegen distress respiratory test from 0 to 64
Time Frame: 1 day
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: César Calvo Lobo, PhD, MSc, PT, European University of Madrid
  • Principal Investigator: David Rodríguez Sanz, PhD, MSc, PT, European University of Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

March 1, 2017

Study Completion (Anticipated)

March 1, 2017

Study Registration Dates

First Submitted

March 24, 2016

First Submitted That Met QC Criteria

April 7, 2016

First Posted (Estimate)

April 13, 2016

Study Record Updates

Last Update Posted (Estimate)

October 7, 2016

Last Update Submitted That Met QC Criteria

October 6, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CIPI/054/15

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Capacitive diathermy (T-CaRe®)

Subscribe